Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H8N4O3 |
Molecular Weight | 196.1634 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(NC(=O)N2)C(=O)N(C)C1=O
InChI
InChIKey=OTSBKHHWSQYEHK-UHFFFAOYSA-N
InChI=1S/C7H8N4O3/c1-10-4-3(8-6(13)9-4)5(12)11(2)7(10)14/h1-2H3,(H2,8,9,13)
Molecular Formula | C7H8N4O3 |
Molecular Weight | 196.1634 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease. | 1988 Sep |
|
Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. | 2001 Aug 15 |
|
Caffeine metabolism before and after liver transplantation. | 2001 Feb |
|
Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. | 2004 Oct |
|
Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. | 2006 May |
|
Nitrosation of N-methyl derivatives of uric acid and their transnitrosation ability to N-acetylcysteine. | 2010 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:36:15 GMT 2023
by
admin
on
Fri Dec 15 18:36:15 GMT 2023
|
Record UNII |
C222JTI9I3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID50241466
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
213-410-1
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
68447
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
95854
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
C031274
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
70346
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
944-73-0
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
C222JTI9I3
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|